Atipamezole hydrochloride,
104075-48-1,
Atipamezole HCl,
Atipamezole (hydrochloride),
1H-Imidazole, 4-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-, monohydrochloride,
4-(2-Ethyl-2,3-dihydro-1H-inden-2-yl)-1H-imidazole hydrochloride,
UNII-2W4279571X,
MPV1248 hydrochloride,
MPV 1248 hydrochloride,
5-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-1H-Imidazole hydrochloride,
AK387105,
2W4279571X,
4-(2-Ethyl-2-indanyl)imidazole hydrochloride,
J-504668,
NCGC00182707-02,
PubChem21910,
atipamezole-hydrochloride,
MPV-1248 hydrochloride,
DSSTox_CID_28509,
DSSTox_RID_82781,
MPV1248 HCl,
DSSTox_GSID_48583,
MPV-1248 HCl,
SCHEMBL203964,
CHEMBL2361649,
DTXSID2048583,
KS-00000MAL,
PCCVCJAQMHDWJY-UHFFFAOYSA-N,
ACT08567,
BCP04113,
Tox21_112912,
MFCD06407819,
s4649,
AKOS015918212,
AKOS025401424,
AC-1613,
BCP9000339,
CS-3389,
RL00198,
AN-14782,
BC653343,
HY-12380,
SC-29046,
SY057281,
AB0010061,
LS-183349,
RT-011331,
B7226,
CAS-104075-48-1,
FT-0656606,
MFCD06407819 (97%),
M-1611,
075A481,
5-(2-ethylindan-2-yl)-1H-imidazole hydrochloride,
5-(2-Ethyl-indan-2-yl)-1H-imidazole hydrochloride,
I14-8140,
5-(2-Ethyl-2,3-dihydro-1H-indene-2-yl)-1H-imidazole hydrochloride,
Antisedan,
C14H17ClN2,
C14-H16-N2.Cl-H,
MPV 1248,
ACN-049658,
CID13649426,
A2956,
A13902,
Atipamezole hydrochloride, 98% - 100MG 100mg,
4-(2-ethyl-1,3-dihydroinden-2-yl)-3H-imidazole Hydrochloride,
104054-27-5,